Learn More
CERILLIANT™ N-Desmethylolanzapine-d8 DiHydrochloride Solution, 100 μg/mL in Acetonitrile:Water, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco D0701ML
Description
A stable-labeled internal standard for use in LC/MS or GC/MS applications including clinical toxicology analysis, therapeutic drug monitoring, or isotope dilution methods. Desmethylolanzapine is the primary metabolite of olanzapine, marketed as the atypical antipsychotic Zyprexa™ for the treatment of schizophrenia and bipolar disorder.
Specifications
| 75-05-8 | |
| UN 1648 3 / PGII | |
| N-Desmethylolanzapine-D8 dihydrochloride solution | |
| Ampule | |
| 13°C (55.4°F) - closed cup |
| C16D8H10N4S · H2Cl2 | |
| 100 μg/mL in acetonitrile:water (1:1) (as free base) | |
| 379.38 | |
| 1 mL |
Safety and Handling
Recommended Storage : 2 to 8°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation